UK Prospective Diabetes Study (UKPDS). Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53. https://doi.org/10.1016/S0140-6736(98)07019-6.

Article  Google Scholar 

Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–39. https://doi.org/10.1056/NEJMoa0808431.

Article  CAS  PubMed  Google Scholar 

ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 2008;358(24):2560–2572 https://doi.org/10.1056/NEJMoa0802987

Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376(9739):419–30. https://doi.org/10.1016/S0140-6736(10)60576-4.

Article  PubMed  PubMed Central  Google Scholar 

Galindo RJ, Trujillo JM, Low Wang CC, McCoy RG. Advances in the management of type 2 diabetes in adults. BMJ Med. 2023;2(1):e000372. https://doi.org/10.1136/bmjmed-2022-000372.

Article  PubMed  PubMed Central  Google Scholar 

Lingvay I, Agarwal S. A revolution in obesity treatment. Nat Med. 2023;29(10):2406–8. https://doi.org/10.1038/s41591-023-02538-7.

Article  CAS  PubMed  Google Scholar 

Fang M, Wang D, Coresh J, Selvin E. Trends in diabetes treatment and control in US adults 1999–2018 N Engl J Med. 2021; 384(23):2219–2228 https://doi.org/10.1056/NEJMsa2032271

• Galindo RJ, Aleppo G. Continuous glucose monitoring: the achievement of 100 years of innovation in diabetes technology Diabetes Res Clin Pract. 2020;170:108502. https://doi.org/10.1016/j.diabres.2020.108502. This article covers the salient advances in CGM technology over time and provides tips on implementation of CGM in the medical office.

Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol. 2013;7(2):562–78. https://doi.org/10.1177/193229681300700234.

Article  PubMed  PubMed Central  Google Scholar 

Das SK, Nayak KK, Krishnaswamy PR, et al. Review—electrochemistry and other emerging technologies for continuous glucose monitoring devices. ECS Sensors Plus. 2022;1(3) https://doi.org/10.1149/2754-2726/ac7abb

Heinemann L, Schoemaker M, Schmelzeisen-Redecker G, et al. Benefits and limitations of MARD as a performance parameter for continuous glucose monitoring in the interstitial space. J Diabetes Sci Technol. 2020;14(1):135–50. https://doi.org/10.1177/1932296819855670.

Article  PubMed  Google Scholar 

Puhr S, Derdzinski M, Welsh JB, Parker AS, Walker T, Price DA. Real-world hypoglycemia avoidance with a continuous glucose monitoring system’s predictive low glucose alert. Diabetes Technol Ther. 2019;21(4):155–8. https://doi.org/10.1089/dia.2018.0359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dexcom G6 User Guide. https://s3-us-west-2.amazonaws.com/dexcompdf/Downloads+and+Guides+Updates/LBL017451+Using+Your+G6%2C+G6%2C+UK%2C+EN%2C+mmol.pdf. Accessed 20 Nov 2023

Dexcom G7 User Guide. https://s3.us-west-2.amazonaws.com/dexcompdf/Downloads+and+Guides+Updates/AW00046-05+UG+G7+OUS+en+MMOL.pdf. Accessed 20 Nov 2023

FreeStyle Libre 2 User Manual. https://freestyleserver.com/Payloads/IFU/2023/q3/ART48230-001_rev-A-web.pdf. Accessed 20 Nov 2023

FreeStyle Libre 3 User Manual. https://freestyleserver.com/payloads/ifu/2023/q3/ART41641-001_rev-A-web.pdf. Accessed 20 Nov 2023

Guardian Sensor 3 User Guide. https://www.medtronicdiabetes.com/sites/default/files/library/download-library/user-guides/Guardian_Sensor_3_User_Guide_Jun-2023.pdf. Accessed 20 Nov 2023

Guardian Sensor 4 User Guide. https://www.medtronicdiabetes.com/sites/default/files/library/download-library/user-guides/Guardian_4_sensor_user_guide.pdf Accessed 20 Nov 2023.

Medtronic News. Medtronic Diabetes announces CE Mark for new Simplera™ CGM with disposable all-in-one design. https://news.medtronic.com/2023-09-21-Medtronic-Diabetes-announces-CE-Mark-for-new-Simplera-TM-CGM-with-disposable-all-in-one-design. Accessed 20 Nov 2023

Eversense E3 User Guide. https://www.eversensediabetes.com/wp-content/uploads/LBL-6002-01-001-Rev-B_Eversense-E3-User-Guide_mgdL_R1.pdf. Accessed November 20, 2023.

Reiterer F, Polterauer P, Schoemaker M, et al. Significance and reliability of MARD for the accuracy of CGM systems. J Diabetes Sci Technol. 2017;11(1):59–67. https://doi.org/10.1177/1932296816662047.

Article  CAS  PubMed  Google Scholar 

Roussel R, Riveline JP, Vicaut E, et al. Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF study. Diabetes Care. 2021;44(6):1368–76. https://doi.org/10.2337/dc20-1690.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wada E, Onoue T, Kobayashi T, et al. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care. 2020;8:1 e001115. https://doi.org/10.1136/bmjdrc-2019-001115.

Article  PubMed  Google Scholar 

Elliott T, Beca S, Beharry R, Tsoukas MA, Zarruk A, Abitbol A. The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: a retrospective real-world chart review study. Diab Vasc Dis Res. 2021;18(4):14791641211021374. https://doi.org/10.1177/14791641211021374.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55–73. https://doi.org/10.1007/s13300-016-0223-6.

Article  CAS  PubMed  Google Scholar 

Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167(6):365–74. https://doi.org/10.7326/M16-2855.

Article  PubMed  Google Scholar 

Martens T, Beck RW, Bailey R, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA. 2021;325(22):2262–72. https://doi.org/10.1001/jama.2021.7444.

Article  CAS  PubMed  Google Scholar 

Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019;42(7):1178–84. https://doi.org/10.2337/dc18-0166.

Article  CAS  PubMed  Google Scholar 

Ehrhardt N, Al ZE. Continuous glucose monitoring as a behavior modification tool. Clin Diabetes. 2020;38(2):126–31. https://doi.org/10.2337/cd19-0037.

Article  PubMed  PubMed Central  Google Scholar 

Aronson R, Brown RE, Chu L, et al. Impact of flash glucose monitoring in people with type 2 diabetes inadequately controlled with non-insulin antihyperglycaemic therapy (IMMEDIATE): a randomized controlled trial. Diabetes Obes Metab. 2023;25(4):1024–31. https://doi.org/10.1111/dom.14949.

Article  CAS  PubMed  Google Scholar 

InPen User Guide. https://www.medtronicdiabetes.com/sites/default/files/library/download-library/user-guides/InPen-user-guide.pdf Accessed 20 Nov 2023

MacLeod J, Im GH, Smith M, Vigersky RA. Shining the spotlight on multiple daily insulin therapy: real-world evidence of the InPen™ smart insulin pen. Diabetes Technol Ther. 2023 https://doi.org/10.1089/dia.2023.0365. https://doi.org/10.1089/dia.2023.0365

Tempo Smart Button User Guide. https://pi.lilly.com/us/tempo-smart-button-ug.pdf Accessed 2 Dec 2023

Bigfoot Unity System User Guide. https://f.hubspotusercontent40.net/hubfs/5085144/PDFs/Bigfoot%20Unity%E2%84%A2%20System%20User%20Guide.pdf. Accessed 2 Dec 2023

ClinicalTrials.Gov. https://clinicaltrials.gov/study/NCT05088265?term=NCT05088265. Accessed 9 Dec 2023

Malone JK, Beck R, Tillman J, et al. 936-P:Three-month interim analysis from the prospective Bigfoot Unity Real World Study (BURST). Diabetes. 2023; 72(Supplement_1): 936–P https://doi.org/10.2337/db23-936-P

Galindo RJ, Ramos C, Cardona S, et al. Efficacy of a smart insulin pen cap for the management of patients with uncontrolled type 2 diabetes: a randomized cross-over trial. J Diabetes Sci Technol. 2023;17(1):201–7. https://doi.org/10.1177/19322968211033837.

Article  CAS  PubMed  Google Scholar 

Ananthanarayanan V, Mithun Haridas TP, Naveen R, et al. Reliable and affordable embedded system solution for continuous blood glucose maintaining system with wireless connectivity to blood glucose measuring system. IJCA Proceedings on Amrita International Conference of Women in Computing. 2013; AICWIC(2):36–43

Reznik Y, Cohen O, Aronson R, et al. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet. 2014;384(9950):1265–72. https://doi.org/10.1016/S0140-6736(14)61037-0.

Article  CAS  PubMed  Google Scholar 

Boughton CK, Hovorka R. Automated insulin delivery in adults. Endocrinol Metab Clin North Am. 2020;49(1):167–78. https://doi.org/10.1016/j.ecl.2019.10.007.

Article  PubMed  Google Scholar 

•• Phillip M, Nimri R, Bergenstal RM, et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice Endocr Rev 2023;44(2):254–280. https://doi.org/10.1210/endrev/bnac022. This article provides an in-depth data about the evidence of AID use, practical tips on initiating AID, and user training tips.

V-Go User Guide. https://www.go-vgo.com/wp-content/uploads/2020/09/ART-1361-rev.B-V-Go-IFU.pdf. Accessed 2 Dec 2023

Cziraky MJ, Abbott S, Nguyen M, et al. A pragmatic clinical trial to compare the real-world effectiveness of V-Go versus standard delivery of insulin in patients with advanced type 2 diabetes. J Health Econ Outcomes Res. 2019 6(2):70–83. https://doi.org/10.36469/9731

Hundal R, Kowalyk S, Wakim A, Nikkel C, Sink Ii JH, Doyle M Multicenter real-world assessment of the effectiveness of V-Go wearable insulin delivery device in adult patients with type 2 diabetes (ENABLE Study): a retrospective analysis. Med Devices (Auckl). 2020;13:283–291 https://doi.org/10.2147/MDER.S265869

Grunberger G, Rosenfeld CR, Bode BW, et al. Effectiveness of V-Go® for patients with type 2 diabetes in a real-world setting: a prospective observational study. Drugs Real World Outcomes. 2020;7(1):31–40. https://doi.org/10.1007/s40801-019-00173-8.

Article  PubMed  Google Scholar 

Cequr Simplicity user guide. https://myceqursimplicity.com/wp-content/uploads/User-Guide.pdf. Accessed 3 Dec 2023

Bergenstal RM, Peyrot M, Dreon DM, et al. Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen. Diabetes Technol Ther. 2019;21(5):273–85. https://doi.org/10.1089/dia.2018.0298.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergenstal RM, Johnson ML, Aroda VR, et al. Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles. J Diabetes Sci Technol. 2022;16(5):1167–73. https://doi.org/10.1177/19322968211016513.

Article  CAS  PubMed  Google Scholar 

Zraick V, Dreon D, Naik R, et al. Patient user experience evaluation of bolus patch insulin delivery system. https://www.jnj.com/sites/default/files/pdf/ada-mae-poster-5-23-16_final.pdf. Accessed 2 Dec 2023

Isaacs D, Kruger DF, Shoger E, Chawla H. Patient perceptions of satisfaction and quality of life regarding use of a novel insulin delivery device. Clin Diabetes. 2023;41(2):198–207. https://doi.org/10.2337/cd22-0034.

Article  PubMed